Blog

by Vineti | March 26, 2021
As the creator of the leading digital platform for orchestrating cell and gene therapies, Vineti knows the operational hurdles faced by advanced therapy clinical trial teams. Here is an overview of some of the key challenges in cell and gene therapy…

by Amy DuRoss | March 25, 2021
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) — A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new and updated standards for advanced therapies. The new collaboration, which…

by Louise Pacini and Amy Fonte | March 24, 2021
Patient-specific therapeutics must be delivered to the patient they are intended to treat. That concept is easy to say -- and not always easy to do. An entire ecosystem of workflows, drug product processes, and supply chain steps must be orchestrated…

by Vineti | February 3, 2021
2020 was a volatile year for cell and gene therapy R&D, but important progress persevered. Here are some of the numbers that mattered most -- and a few that point to a coming rebound.

by Amy DuRoss | January 11, 2021
SAN FRANCISCO, January 11, 2020 (Globe Newswire) — Vineti, the leading provider of a digital platform of record for personalized therapeutics, today announced a new suite of flexibility features for its Personalized Therapy Management® (PTM)…

  • 1 (current)
  • 2
Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required